BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Procyon BioPharma Inc. 

1650 Trans-Canada, Suite 200

Montreal  Quebec  H9P1H7  Canada
Phone: 514-685-9283 Fax: 514-685-5138


SEARCH JOBS


Industry
Biotechnology






 Company News
Procyon BioPharma Inc. (PBP.TO) Announces Completion Of The Acquisition Of Cellpep S.A. And The Concurrent Private Placement 3/2/2006 11:43:17 AM    More...
Procyon BioPharma Inc. (PBP.TO) Shareholders Approve Merger Via Acquisition With Cellpep S.A. 2/24/2006 12:07:55 PM    More...
Procyon BioPharma Inc. (PBP.TO) To Webcast Special Meeting Of Shareholders To Approve Merger Via Acquisition With Cellpep And $18.1 Million Financing 2/16/2006 12:17:45 PM    More...
Procyon BioPharma Inc. (PBP.TO) And Cellpep To Merge Via Acquisition Creating A New Global Biopharmaceutical Company, Ambrilia Biopharma Inc. 1/19/2006 12:33:06 PM    More...
Procyon BioPharma Inc. (PBP.TO) To Receive $1 Million In Contribution From NRC-IRAP For Its HIV/AIDS Study 1/13/2006 11:17:28 AM    More...
Procyon BioPharma Inc. (PBP.TO) Receives Regulatory Approval To Commence Phase 1 Clinical Trial For Its Lead HIV Protease Inhibitor, PPL-100 12/8/2005 10:07:32 AM    More...
Procyon BioPharma Inc. (PBP.TO) To Host Conference Call And Webcast To Explain PSP94 Diagnostic Marker Study Findings 12/5/2005 11:16:04 AM    More...
Study Shows Procyon BioPharma Inc. (PBP.TO)'s PSP94 Diagnostic Marker Is Better At Detecting Aggressive Prostate Cancer - Toronto Study To Be Published In Prestigious Journal Of Urology 12/2/2005 11:08:04 AM    More...
Procyon BioPharma Inc. (PBP.TO) To Host Conference Call And Webcast Today To Explain New Data For PPL-100 11/16/2005 2:10:09 PM    More...
Procyon BioPharma Inc. (PBP.TO) Reports New Data For Its Lead HIV Protease Inhibitor, PPL-100, Showing A Potentially High Genetic Barrier Against The HIV Virus 11/16/2005 10:48:03 AM    More...
1234567

//-->